Loading market data...
GrantExec
GrantExec

Questions? Contact Us

ยฉ 2025 GrantExec. All rights reserved.

Health for State governments Grants

Explore 1,133 grant opportunities

Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 21, 2025

Date Added

Dec 11, 2024

This funding opportunity supports research teams from various sectors to explore how sex differences influence the biological factors related to Alzheimerโ€™s disease and its treatment, aiming to enhance understanding and improve precision medicine approaches.

Health
State governments
Complement-ARIE New Approach Methodologies (NAMs) Technology Development Centers (UM1 Clinical Trial Optional)
Contact for amount
US Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Mar 18, 2025

Date Added

Dec 11, 2024

This funding opportunity supports U.S.-based institutions and organizations in developing innovative human-based research models to improve understanding of health and disease, with a focus on inclusivity and collaboration.

Health
State governments
Limited Competition: Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 - Clinical Trial Optional)
$3,500,000
US Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Jan 25, 2025

Date Added

Dec 10, 2024

This funding opportunity provides financial support to U.S. institutions focused on improving minority health and reducing health disparities by enhancing research capacity, fostering investigator development, and promoting community engagement.

Health
State governments
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
$1,515,000
US Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Jan 5, 2025

Date Added

Dec 10, 2024

This funding opportunity supports researchers conducting early-phase clinical trials for new treatments and diagnostics related to heart, lung, blood, and sleep disorders in both adults and children.

Health
State governments
Coordination Center for the Alzheimers Disease Sequencing Project Consortium (U01 Clinical Trial Not Allowed)
$1,000,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Mar 14, 2025

Date Added

Dec 10, 2024

This funding opportunity is designed to establish a central hub that will support collaborative genetic research on Alzheimerโ€™s disease and related dementias, focusing on diverse populations and innovative data-sharing practices.

Health
State governments
Occupational Safety and Health Research (R01)
$400,000
U.S. Department of Health & Human Services (Centers for Disease Control and Prevention - ERA)
Federal

Application Deadline

Not specified

Date Added

Dec 10, 2024

This funding opportunity supports research projects that aim to improve workplace safety and health by identifying and addressing occupational hazards, ultimately reducing injuries and illnesses among workers.

Health
State governments
Connecting Organizations and People to Empower Diabetes Prevention and Treatment (Connections)
$350,000
US Department of Health & Human Services (Centers for Disease Control and Prevention - ERA)
Federal

Application Deadline

Jan 6, 2025

Date Added

Dec 10, 2024

This funding opportunity provides financial support for a variety of organizations to research and improve programs that connect communities and healthcare resources to reduce diabetes-related health disparities.

Health
State governments
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
$300,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Not specified

Date Added

Dec 10, 2024

This funding opportunity provides financial support for short-term clinical trials aimed at improving treatments for arthritis, musculoskeletal, and skin diseases, targeting researchers and institutions focused on innovative healthcare solutions.

Health
State governments
Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
$300,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Not specified

Date Added

Dec 10, 2024

This funding opportunity supports researchers conducting time-sensitive studies that enhance ongoing clinical projects related to arthritis, musculoskeletal, and skin diseases, aiming to improve understanding and treatment of these conditions.

Health
State governments
NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
$250,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Not specified

Date Added

Dec 10, 2024

This funding opportunity supports researchers at U.S. institutions in conducting clinical trials focused on improving treatments for arthritis, musculoskeletal, and skin diseases.

Health
State governments
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
$250,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Not specified

Date Added

Dec 10, 2024

This funding opportunity supports researchers conducting observational studies to improve understanding and treatment of musculoskeletal, rheumatic, and skin diseases, ultimately informing future clinical trials.

Health
State governments
Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
$250,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Not specified

Date Added

Dec 10, 2024

This funding opportunity supports innovative, time-sensitive research projects that enhance ongoing clinical studies related to arthritis, musculoskeletal, and skin diseases by leveraging existing patient data and samples.

Health
State governments
Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed)
$100,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 19, 2025

Date Added

Dec 10, 2024

This funding opportunity provides financial support to early-career researchers who have received specific NIAMS awards, enabling them to conduct small-scale studies and gather data to advance their research and secure future funding.

Health
State governments
K01 Mentored Research Scientist Development Award
$100,000
U.S. Department of Health & Human Services (Centers for Disease Control and Prevention - ERA)
Federal

Application Deadline

Not specified

Date Added

Dec 10, 2024

This funding opportunity supports early-career scientists in the U.S. who are focused on conducting impactful research to improve worker health and safety in various occupational settings.

Health
State governments
State Loan Repayment Program
$15,000,000
US Department of Health & Human Services (Health Resources and Services Administration)
Federal

Application Deadline

May 20, 2025

Date Added

Dec 10, 2024

This funding opportunity provides financial support to state governments to create loan repayment programs that encourage primary care providers to work in underserved areas facing healthcare provider shortages.

Health
State governments
NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
Contact for amount
US Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Jan 7, 2025

Date Added

Dec 10, 2024

This funding opportunity supports researchers in conducting observational studies or validating biomarkers related to dental, oral, and craniofacial diseases, aiming to improve prevention, diagnosis, and treatment through prospective data collection and analysis.

Health
State governments
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
Contact for amount
US Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Jan 8, 2025

Date Added

Dec 10, 2024

This funding opportunity provides financial support for researchers to conduct early-phase clinical trials aimed at developing new treatments or diagnostic tools for heart, lung, blood, and sleep disorders in both adults and children.

Health
State governments
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
$200,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Not specified

Date Added

Dec 9, 2024

This funding opportunity supports research institutions and organizations in conducting preclinical studies to develop new therapies for rare diseases affecting fewer than 200,000 people in the U.S.

Health
State governments
Ryan White HIV/AIDS Program (RWHAP) Access, Care, and Engagement Technical Assistance Center (ACE TA)
$375,000
U.S. Department of Health & Human Services (Health Resources and Services Administration)
Federal

Application Deadline

Feb 11, 2025

Date Added

Dec 9, 2024

This funding opportunity provides financial support to organizations that help people with HIV access healthcare coverage and improve their health outcomes through education and outreach efforts.

Health
State governments
NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 Independent Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Not specified

Date Added

Dec 9, 2024

This funding opportunity supports researchers and institutions conducting early-phase clinical trials for heart, lung, blood, and sleep disorders, aiming to evaluate the safety and feasibility of new diagnostic and therapeutic interventions.

Health
State governments